Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression
- 1 October 2000
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 25 (5), 363-371
- https://doi.org/10.1046/j.1365-2710.2000.00302.x
Abstract
To establish the therapeutic effect profile of sertraline in major depression. It was hypothesized that the antidepressant effect of sertraline showed three phases: Phase 1 where improvements in anxiety are most pronounced; Phase 2 where the greatest improvements are in depressive symptoms; and Phase 3 where the symptoms of anhedonia show the most improvement. To test this hypothesis, an 8-week, open-label study was conducted. Patients with a major depressive episode (DSM-IV) and a score > or = 24 on the 17-item HAM-D were enrolled and treated with sertraline 50-150 mg/day. The three symptomatic clusters, anxiety, depression and hedonia, were defined a priori using the Inventory of Depressive Symptomatology-Clinician rated (IDS-C). Periods of interest were: Days 0-7 for anxiety, Days 7-21 for depression and Days 21-56 for anhedonia. Raters were blinded as to the constitution of the clusters and periods. 140 patients were recruited. Improvement in the anxiety cluster of the IDS-C was greatest during Days 0-7, whereas over Days 7-21 most improvement was observed in the depression cluster and the greatest improvement in the hedonic cluster occurred during Days 21-56. These preliminary results are consistent with the hypothesis that the therapeutic effects of sertraline occur in a sequential manner. The symptoms of anxiety improved first, followed by depression and then anhedonia.Keywords
This publication has 21 references indexed in Scilit:
- Involvement of Serotonin and Dopamine in the Mechanism of Action of Novel Antidepressant DrugsJournal of Clinical Psychopharmacology, 1998
- A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depressionEuropean Psychiatry, 1997
- P-12-4: Predictors of response to SSRIs in patients with major depressionEuropean Neuropsychopharmacology, 1996
- The Inventory of Depressive Symptomatology (IDS): psychometric propertiesPsychological Medicine, 1996
- A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depressionHuman Psychopharmacology: Clinical and Experimental, 1995
- Serotonin Receptor SubtypesCNS Drugs, 1995
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs)Nordic Journal of Psychiatry, 1993
- The Biochemistry of Affective DisordersThe British Journal of Psychiatry, 1967
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960